Ra Pharmaceuticals Inc (RARX) Stock Price, Quote, News and Overview
NASDAQ:RARX - Nasdaq -
RARX Quote, Performance and Key Statistics
47.995
-0.02 (-0.03%)
The current stock price of RARX is 47.995 null. In the past month the price increased by 2.2%. In the past year, price increased by 104.15%.
About RARX
Company Profile
Ra Pharmaceuticals, Inc. is a biopharmaceutical company. It involved in the discovery and development of novel therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system. Ra Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Company Info
Ra Pharmaceuticals Inc
87 CAMBRIDGE PARK DRIVE
CAMBRIDGE MA 02140
CEO: Douglas A. Treco
Phone: 617-401-4060
Ra Pharmaceuticals Inc / RARX FAQ
What is the stock price of Ra Pharmaceuticals Inc today?
The current stock price of RARX is 47.995 null. The price decreased by -0.03% in the last trading session.
What is the ticker symbol for Ra Pharmaceuticals Inc stock?
The exchange symbol of Ra Pharmaceuticals Inc is RARX and it is listed on the Nasdaq exchange.
On which exchange is RARX stock listed?
RARX stock is listed on the Nasdaq exchange.
What is Ra Pharmaceuticals Inc worth?
Ra Pharmaceuticals Inc (RARX) has a market capitalization of 2.27B null. This makes RARX a Mid Cap stock.
What are the support and resistance levels for Ra Pharmaceuticals Inc (RARX) stock?
Ra Pharmaceuticals Inc (RARX) has a support level at 47 and a resistance level at 48.01. Check the full technical report for a detailed analysis of RARX support and resistance levels.
Should I buy Ra Pharmaceuticals Inc (RARX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RARX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RARX, evaluating the profitability, health, valuation and growth aspects
- Ra Pharmaceuticals Inc (RARX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Ra Pharmaceuticals Inc (RARX) Sales and EPS estimates to see what analysts future expectations are.
- Ra Pharmaceuticals Inc (RARX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Ra Pharmaceuticals Inc (RARX) Insider and Institutional Ownership to learn about the owners and their transactions.
- Ra Pharmaceuticals Inc (RARX) Stock Chart to make your own analysis
- Ra Pharmaceuticals Inc (RARX) Latest news and press-releases to stay up to date.
Does Ra Pharmaceuticals Inc (RARX) stock pay dividends?
RARX does not pay a dividend.
What is the Price/Earnings (PE) ratio of Ra Pharmaceuticals Inc (RARX)?
Ra Pharmaceuticals Inc (RARX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.31).
RARX Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to RARX. When comparing the yearly performance of all stocks, RARX is one of the better performing stocks in the market, outperforming 98.34% of all stocks.
RARX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to RARX. While RARX has a great health rating, there are worries on its profitability.
RARX Financial Highlights
Over the last trailing twelve months RARX reported a non-GAAP Earnings per Share(EPS) of -2.31. The EPS decreased by -12.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -3422.93% | ||
| ROA | -36.14% | ||
| ROE | N/A | ||
| Debt/Equity | 0.01 |
RARX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 60% to RARX. The Buy consensus is the average rating of analysts ratings from 7 analysts.